Friedman Paul A (CIK 0001236927)

Latest company ownership

INCY - INCYTE CORP
Role: Director
Shares held
269,011
Last filed at
Nov 20, 2017
Confidence Score
50.0
2025Q4
Confidence Score History
2017Q4 2025Q4
Shares held
161,128
Last filed at
Nov 23, 2018
Confidence Score
33.6
2025Q4
Confidence Score History
2018Q2 2025Q4
VSTM - Verastem, Inc.
Role: Director
Shares held
3,000
Last filed at
Dec 29, 2014
Confidence Score
50.0
2025Q4
Confidence Score History
2014Q4 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Dec 10, 2025 Dec 12, 2025 MADRIGAL PHARMACEUTICALS, INC. Director Sell 33.8 -24,800 -2.86% ✓ $13.7M
Aug 13, 2025 Aug 13, 2025 MADRIGAL PHARMACEUTICALS, INC. Director Sell 17.5 -129,172 -13.29% ✓ $47.8M
Aug 11, 2025 Aug 13, 2025 MADRIGAL PHARMACEUTICALS, INC. Director Sell 37.5 -46,808 -1.48% ✓ $16.6M
Jul 18, 2025 Jul 22, 2025 MADRIGAL PHARMACEUTICALS, INC. Director Sell 47.5 -1,400 -0.17% ✓ $490K
Jul 16, 2025 Jul 18, 2025 MADRIGAL PHARMACEUTICALS, INC. Director Sell 37.5 -28,876 -1.18% ✓ $10.2M
Apr 8, 2024 Apr 10, 2024 MADRIGAL PHARMACEUTICALS, INC. Director Sell 31.3 -26,270 -3.03% ✓ $6.5M
Apr 3, 2024 Apr 5, 2024 MADRIGAL PHARMACEUTICALS, INC. Director Sell 37.5 -73,730 -1.59% ✓ $18M
Jan 16, 2023 Jan 18, 2024 MADRIGAL PHARMACEUTICALS, INC. Director Sell 45.0 -2,254 -0.33% ✗ $549.8K
Aug 2, 2019 Aug 6, 2019 INCYTE CORP Director Sell 16.3 -100,000 -14.90% ✗ $8.3M
Nov 20, 2018 Nov 23, 2018 MADRIGAL PHARMACEUTICALS, INC. CEO Buy 90.0 +4,000 2.55% ✗ $471.5K
Nov 19, 2018 Nov 19, 2018 MADRIGAL PHARMACEUTICALS, INC. CEO Buy 90.0 +4,000 2.61% ✗ $496K
Jun 11, 2018 Jun 12, 2018 MADRIGAL PHARMACEUTICALS, INC. CEO Sell 15.0 -73,526 -10.08% ✗ $21.1M
Nov 16, 2017 Nov 20, 2017 INCYTE CORP Director Sell 17.5 -28,507 -9.58% ✗ $3M
Dec 24, 2014 Dec 29, 2014 Verastem, Inc. Director Buy 91.3 +3,000 100.00% ✗ $24.9K